Lonza Group AG stock faces pressure amid biotech slowdown as of March 2026

Endpoints NewsLilly plans new $4.5B manufacturing investment in Indiana

Endpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2

Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansion

FierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to US

Clinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 Diabetes

Clinical OMICsEpigenetic Markers Link Early-Onset Colon and Rectal Cancer to Specific Pesticide

Clinical OMICsBlood Test Reads Cell Spatial Environment to Predict Immunotherapy Response

Clinical OMICsPancreatic Cancer Shares Genetic Drivers with Obesity and Diabetes

Clinical OMICsAdvanced Cardiovascular-Kidney-Metabolic Syndrome Linked to Increased Cancer Risk

BioPharma DiveBayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline

BioWorldAppointments and advancements for May 6, 2026

BioWorldFinancings for May 6, 2026